Obesity trials recruiting in Texas

All Obesity trials nationally

Cities in Texas

Recruiting trials in Texas

• A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
  NCT07351045 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Bellaire, Brownsville, Corpus Christi, Dallas
• A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
  NCT07351058 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Brownsville, Dallas, Edinburg, Houston
• A First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or Obesity
  NCT07767175 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · Texas: San Antonio
• A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
  NCT06143956 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: Austin, Dallas, Houston, San Antonio
• A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
  NCT07667803 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Dallas, Houston, Humble, Irving
• A Phase 2 Study to Evaluate the Pharmacodynamics, Safety and Tolerability of BGE-102 in Participants With Obesity and Cardiovascular Risk Factors
  NCT07656727 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Austin, San Antonio
• A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
  NCT06672549 · Phase: Phase 3 · Ages: 6 Years to 17 Years · Sex: All (male and female) · Texas: Austin, Corpus Christi, Houston, Tomball
• A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity
  NCT07639021 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Houston, San Antonio
• A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
  NCT06717698 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Texas: El Paso, San Antonio
• A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
  NCT07481630 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: San Antonio
• A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
  NCT07253285 · Phase: Phase 3 · Ages: 8 Years to 18 Years · Sex: All (male and female) · Texas: Houston, San Antonio, Shavano Park, Weslaco
• A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
  NCT07564414 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Amarillo, Austin, Dallas, Euless
• A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
  NCT07567001 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Amarillo, Austin, Conroe, Corpus Christi
• A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
  NCT07654374 · Phase: Phase 3 · Ages: 18 Years to 79 Years · Sex: All (male and female) · Texas: Austin, Farmers Branch, Houston, San Antonio
• A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight
  NCT07738614 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Texas: San Antonio
• A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
  NCT07282600 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Austin, Corpus Christi, Dallas, Fort Worth
• A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
  NCT07321886 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Bellaire, Dallas, San Antonio
• A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
  NCT07369011 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Austin, San Antonio, Shavano Park
• A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
  NCT07392190 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Dallas, Houston, Kingwood, Mission
• A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
  NCT06897475 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: Houston, Mesquite, Round Rock, Shavano Park
• A Study of LY4174794 in Participants With Obesity or Overweight Who Are Otherwise Healthy
  NCT07654972 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Texas: San Antonio
• A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
  NCT07215559 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: Dallas, Houston, Richmond, Shavano Park
• A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
  NCT07743450 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Austin, Brownsville, DeSoto, Frisco
• A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
  NCT07743463 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Austin, Brownsville, DeSoto, Frisco
• A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities
  NCT06672939 · Phase: Phase 3 · Ages: 12 Years to 17 Years · Sex: All (male and female) · Texas: Houston, Tomball
• A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
  NCT07153471 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Dallas, Houston, Kingwood, The Woodlands
• A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
  NCT07202884 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Female · Texas: Houston
• A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)
  NCT07575932 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Euless, Houston, Kingwood, Plano
• A Study of Pitolisant in Patients With Prader-Willi Syndrome
  NCT06366464 · Phase: Phase 3 · Ages: 6 Years and older · Sex: All (male and female) · Texas: Houston, San Antonio, Weslaco
• A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment
  NCT06239116 · Phase: Phase 1, Phase 2 · Ages: 12 Years to 65 Years · Sex: All (male and female) · Texas: San Antonio
• A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)
  NCT06439277 · Phase: Phase 3 · Ages: 12 Years to 17 Years · Sex: All (male and female) · Texas: Corpus Christi, DeSoto, Fort Worth, Shavano Park
• A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
  NCT07784725 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Houston, San Antonio, Sugar Land, Waco
• A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use
  NCT07446439 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Texas: Plano, San Antonio
• A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets
  NCT07652047 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: Female · Texas: Austin
• A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
  NCT06864026 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Colleyville, Fort Worth, Houston, Irving
• A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
  NCT07589608 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: Austin, Dallas, Houston, San Antonio
• A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
  NCT06857942 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Bellaire, Dallas, Houston, Pflugerville
• A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
  NCT07595549 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Houston, San Antonio
• A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
  NCT07477704 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Texas: Dallas, Fort Worth, Round Rock, San Antonio
• A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or Overweight
  NCT07662122 · Phase: Phase 2 · Ages: 18 Years to 74 Years · Sex: All (male and female) · Texas: Austin, Brownsville, Edinburg, San Antonio
• A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight
  NCT07441252 · Phase: Phase 2 · Ages: 18 Years to 99 Years · Sex: All (male and female) · Texas: Bellaire, Corpus Christi, Edinburg, Houston
• AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight Loss
  NCT07503210 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Dallas
• AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
  NCT07339423 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Amarillo, Dallas, Forney
• AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
  NCT07533175 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Dallas, Houston
• AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
  NCT07571005 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: DeSoto, El Paso, Houston, San Antonio
• AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
  NCT07571109 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: DeSoto, El Paso, Houston, San Antonio
• AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
  NCT07509307 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Dallas
• Adapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic Adolescents
  NCT06943001 · Phase: Not applicable (e.g. observational or device study) · Ages: 14 Years to 16 Years · Sex: All (male and female) · Texas: Houston
• Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
  NCT05082519 · Phase: Phase 2 · Ages: 7 Years to 25 Years · Sex: All (male and female) · Texas: Dallas, Houston
• Comparing Outcomes Among Children With Obesity in a Community Healthy Lifestyle Program
  NCT07342855 · Phase: Not applicable (e.g. observational or device study) · Ages: 6 Years to 14 Years · Sex: All (male and female) · Texas: Dallas
• Determinants of Insulin Sensitivity by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis
  NCT05950282 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Texas: Houston
• Effects of Obesity in the Aged
  NCT05028309 · Phase: Not applicable (e.g. observational or device study) · Ages: 65 Years to 75 Years · Sex: All (male and female) · Texas: Dallas
• Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults
  NCT06811324 · Phase: Phase 2 · Ages: 50 Years and older · Sex: All (male and female) · Texas: San Antonio
• Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
  NCT07654361 · Phase: Phase 3 · Ages: 18 Years to 79 Years · Sex: All (male and female) · Texas: Austin, Denison, Houston, San Antonio
• Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
  NCT07353931 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Bellaire, DeSoto, Fort Worth, Houston
• Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Related Comorbidity
  NCT07497880 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: Austin, Brownsville, Farmers Branch, Fort Worth
• Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
  NCT07284979 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Brownsville, San Antonio
• Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
  NCT07284901 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Amarillo, Brownsville, DeSoto, El Paso
• Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
  NCT07284875 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Amarillo, Bellaire, DeSoto, Tomball
• Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
  NCT07575399 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female) · Texas: DeSoto, Edinburg, Houston, McKinney
• Endoscopic Sleeve Gastroplasty (ESG) for the Treatment of Obesity
  NCT06339320 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Texas: Houston, Sugar Land
• Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
  NCT07037433 · Phase: Phase 3 · Ages: 45 Years to 99 Years · Sex: All (male and female) · Texas: Amarillo, Austin, Dallas, El Paso
• Evaluating the Impact of a School-based Fruit and Vegetable Co-op on Cardiometabolic Child and Parents Health in a Persistent Poverty Area
  NCT06570707 · Phase: Not applicable (e.g. observational or device study) · Ages: 6 Years to 9 Years · Sex: All (male and female) · Texas: Houston
• Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
  NCT07607587 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Amarillo, Austin
• Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
  NCT07684235 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female) · Texas: Austin, Bellaire, Dallas, DeSoto
• Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
  NCT07684144 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female) · Texas: Austin, Bellaire, Corpus Christi, Denison
• Genetic Disorders of Obesity Program Database
  NCT05747976 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Texas: Houston
• Healthy Living BEYOND Weight Study
  NCT07075341 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Texas: Dallas
• Impact of Dietary Phosphate Excess on Exercise Capacity and Visceral Adiposity
  NCT05147909 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · Texas: Dallas
• Improving Glycemic Control With Electrical Stimulation
  NCT03947697 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Texas: El Paso
• Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweight/Obesity)
  NCT07480109 · Phase: Not applicable (e.g. observational or device study) · Ages: 30 Years to 60 Years · Sex: Female · Texas: Austin
• Incretin Microdosing for Cardiometabolic Health in People With HIV
  NCT07325500 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Houston
• Integrating Food Rx With Best Feeding Practices With EFNEP
  NCT05881759 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 64 Years · Sex: All (male and female) · Texas: Houston
• Lean Beef as Part of a Healthy Meal Plan in Adolescents With Polycystic Ovary Syndrome (PCOS)/Polyendocrine Metabolic Ovarian Syndrome (PMOS)
  NCT07780188 · Phase: Not applicable (e.g. observational or device study) · Ages: 11 Years to 17 Years · Sex: Female · Texas: College Station
• Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy
  NCT07226765 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female) · Texas: Austin, DeSoto, San Antonio
• Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy
  NCT07225686 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female) · Texas: Austin, DeSoto, San Antonio
• Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
  NCT07037459 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female) · Texas: Amarillo, Austin, Conroe, Dallas
• Mechanical Ventilation in Obese Surgical Patients
  NCT07774065 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Texas: Galveston
• Metformin IN Asthma for Overweight and Obese Individuals (MINA)
  NCT06273072 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Houston
• Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
  NCT06937086 · Phase: Phase 3 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Texas: San Antonio, Tyler
• Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
  NCT06937099 · Phase: Phase 3 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Texas: San Antonio, Tyler
• Modifying Adiposity Through Behavioral Strategies to Improve COVID-19 Rehabilitation
  NCT05880108 · Phase: Not applicable (e.g. observational or device study) · Ages: Up to 80 Years · Sex: All (male and female) · Texas: San Antonio
• Mothers and CareGivers Investing in Children Study 2.0
  NCT06719102 · Phase: Not applicable (e.g. observational or device study) · Ages: 0 Years to 90 Years · Sex: All (male and female) · Texas: Austin
• Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery
  NCT04003038 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · Texas: Houston
• Neuromuscular Electrical Stimulation: A Novel Treatment for Improving Metabolism
  NCT06722391 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · Texas: El Paso
• Nurturing Needs Study: Parenting Food Motivated Children
  NCT06111040 · Phase: Not applicable (e.g. observational or device study) · Ages: 4 Years to 5 Years · Sex: All (male and female) · Texas: Houston
• PATHS-UP Health Behavior Self-monitoring Mobile App for Adolescents
  NCT06959901 · Phase: Not applicable (e.g. observational or device study) · Ages: 12 Years to 18 Years · Sex: All (male and female) · Texas: Houston
• Pilot Testing a Novel Approach to Pediatric Obesity Treatment
  NCT06755827 · Phase: Phase 1, Phase 2 · Ages: 11 Years to 14 Years · Sex: All (male and female) · Texas: Lubbock
• Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants
  NCT05838287 · Phase: Phase 4 · Ages: 30 Years to 70 Years · Sex: All (male and female) · Texas: San Antonio
• Postextubation Use of Noninvasive Respiratory Support in Severely Obese Patients
  NCT05918575 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Texas: Houston
• Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study
  NCT06759701 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: Male · Texas: Houston
• Prevention of Progression of Prediabetes, Obesity and CV Risk
  NCT06446531 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Texas: San Antonio
• Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss
  NCT07446998 · Phase: Phase 2 · Ages: 65 Years to 100 Years · Sex: All (male and female) · Texas: Irving
• RESET System Pivotal Trial (Rev F)
  NCT04101669 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years to 65 Years · Sex: All (male and female) · Texas: Houston
• Reducing Obesity Through Play Among Toddlers: Tiny Steps to Health (TSHS) Study
  NCT06918821 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Months to 36 Months · Sex: All (male and female) · Texas: Houston
• Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
  NCT07770841 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Dallas
• Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
  NCT07752979 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: Amarillo, Dallas, Longview
• Self-monitoring Focus Groups With Vibrant Lives Pasadena Participants
  NCT04611087 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Texas: Houston
• Semaglutide for Post-Smoking Cessation Weight Management
  NCT06173778 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: Austin, Houston
• Single and Multiple Ascending Dose Study of AMG 513 in Participants With Obesity
  NCT06585462 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Texas: Austin